Results 71 to 80 of about 31,546 (239)
Identification of novel neutralizing determinants for protection against HCV
Identification of novel neutralizing determinants for protection against hepatitis C virus. Abstract Background and Aims HCV evasion of neutralizing antibodies (nAb) results in viral persistence and poses challenges to the development of an urgently needed vaccine.
Garazi P. Alzua +12 more
wiley +1 more source
Epidemiology of hepatitis virus in the Colombian Amazon after 15 years of hepatitis B vaccination.
Hepatitis B virus infection (HBV) is an endemic public health problem in many countries around the globe. Latin America (LA) is considered an area of low and medium endemicity for hepatitis B infection. A highly effective vaccine has been available since
De la Hoz Restrepo, Fernando
core
The uncovered IKKβ‐USP28‐HEY1 axis fuels cancer stemness and immune evasion in hepatocellular carcinoma. USP28 deubiquitinates HEY1 upon IKKβ‐mediated phosphorylation, conferring PD‐1/PD‐L1 blockade resistance. Pharmacological inhibition of USP28 sensitizes resistant tumors to anti‐PD‐1 immunotherapy, revealing a promising therapeutic strategy ...
Na Shao +8 more
wiley +1 more source
c‐Rel–dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis
In response to genotoxic injury, c‐Rel upregulates ATM‐Chk2‐p53 pathway DNA damage proteins to limiting hepatocarcinogenesis. Abstract Background and Aims Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related death. The NF‐κB transcription factor family subunit c‐Rel is typically protumorigenic; however, it has recently been reported as a
Jack Leslie +17 more
wiley +1 more source
This study proposed a unified sequence‐based framework for protein binding site prediction, which adopted a tri‐track semantic multi‐source feature fusion strategy to effectively capture diverse macromolecular interaction sites and further improved the accuracy of antibody‐antigen interaction prediction.
Dongliang Hou +8 more
wiley +1 more source
TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk
The systematic approach in elucidating the gain‐of‐function (GOF) roles of TP53 mutations in early liver carcinogenesis. Unique downstream targets of TP53 L3 mutations were identified from chormatin immunoprecipitation sequencing in HCC cell lines, followed by a series of validation assays to substantiate the exclusive transcriptional regulations ...
Yin Kau Lam +10 more
wiley +1 more source
Comportamiento de la Hepatitis C en donantes de sangre
Se realizó un estudio prospectivo de los donantes habituales de sangre de los bancos municipales de 10 de Octubre y Guanabacoa durante el año 1999, donde se encontraron 50 pacientes con el antígeno C positivo para la hepatitis.
Marcia Almuiña Güemes +3 more
doaj
Introduction and aim: Hepatitis C virus infection and chronic kidney disease are major public health issues all over the world. It has been suggested a role of HCV as a risk factor for the development and progression of chronic kidney disease (defined by
Fabrizio Fabrizi +5 more
doaj +1 more source
Papel de la vía de señalización de la insulina y mTOR en la infección por el virus de la Hepatitis C. Implicación en el desarrollo de carcinoma hepatocelular [PDF]
Introducción El virus de la hepatitis C (VHC) promueve resistencia a la insulina (RI) y el desarrollo de esteatosis. Al progresar la enfermedad puede provocar la aparición de fibrosis hepática, cirrosis y carcinoma hepatocelular (HCC).
García-Valdecasas Merino, Marta María
core
This study identifies p300 as the acetyltransferase that acetylates TBK1 and inhibits its phosphorylation. Activation of the p53‐SIAH1 axis by immune response downregulates p300 expression to sustain innate antiviral immunity. Conditional p300 knockout in alveolar epithelial cells in vivo promotes antiviral responses and suppresses virus replication ...
Huidi Yu +6 more
wiley +1 more source

